HOSPITAL UNIVERSITARIO RUBER
Departamento
Baylor University Medical Center
Dallas, Estados UnidosPublicaciones en colaboración con investigadores/as de Baylor University Medical Center (1)
2019
-
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study
Annals of Oncology, Vol. 30, Núm. 3, pp. 397-404